• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Afya Limited

    12/20/24 7:06:54 PM ET
    $AFYA
    Other Consumer Services
    Real Estate
    Get the next $AFYA alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 32)*


    Afya Ltd

    (Name of Issuer)


    Class A Common Shares, par value $0.00005 per share

    (Title of Class of Securities)


    G01125106

    (CUSIP Number)


    Denise Abel
    Bertelsmann SE & Co. KGaA, Carl-Bertelsmann-Strasse 270
    Gutersloh, 2M, 33311
    49-0-5241-80-2551

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    12/18/2024

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    G01125106


    1 Name of reporting person

    Bertelsmann SE & Co. KGaA
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    GERMANY
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    59,731,836.00
    9Sole Dispositive Power

    59,731,836.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    59,731,836.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    74.20 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    (1) Aggregate amount beneficially owned by Bertelsmann SE & Co. KGaA (Bertelsmann) and Erste WV Gutersloh GmbH, a wholly-owned direct subsidiary of Bertelsmann (Erste and collectively with Bertelsmann, the Reporting Person) consists of 34,074,134 Class B common shares and 25,657,702 Class A common shares held of record by the Reporting Person. Each Class B common share held of record by the Reporting Person is convertible into one Class A common share at the option of its holder at any time. (2) Represents the quotient obtained by dividing (a) the number of Class B common shares and Class A common shares beneficially owned by the Reporting Person as set forth in Row 11 by (b) the sum of (i) 46,426,830 Class A common shares outstanding as of September 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Securities and Exchange Commission (the Commission) on November 13, 2024 (as reduced by the number of treasury shares reported therein), and (ii) the aggregate number of Class B common shares beneficially owned by the Reporting Person. The aggregate number of Class B common shares beneficially owned by the Reporting Person as set forth in clauses (a) and (b) of this footnote are treated as converted into Class A common shares only for the purpose of computing the percentage ownership of the Reporting Person. As of September 30, 2023, the number of Class A common shares outstanding was 44,009,699 and the percentage beneficially owned was 58.06percent. (3) Each Class A common share is entitled to one vote, and each Class B common share is entitled to ten votes. The percentage reported does not reflect the ten for one voting power of the Class B common shares because the Class B common shares are treated as converted into Class A common shares for the purpose of this report.


    SCHEDULE 13D

    CUSIP No.
    G01125106


    1 Name of reporting person

    Erste WV Gutersloh GmbH
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    GERMANY
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    59,731,836.00
    9Sole Dispositive Power

    59,731,836.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    59,731,836.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    74.20 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    (1) Aggregate amount beneficially owned by Bertelsmann SE & Co. KGaA (Bertelsmann) and Erste WV Gutersloh GmbH, awholly-owned direct subsidiary of Bertelsmann (Erste and collectively with Bertelsmann, the Reporting Person) consists of34,074,134 Class B common shares and 25,657,702 Class A common shares held of record by the Reporting Person. EachClass B common share held of record by the Reporting Person is convertible into one Class A common share at the optionof its holder at any time. (2) Represents the quotient obtained by dividing (a) the number of Class B common shares and Class A common sharesbeneficially owned by the Reporting Person as set forth in Row 11 by (b) the sum of (i) 46,426,830 Class A common sharesoutstanding as of September 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Securitiesand Exchange Commission (the Commission) on November 13, 2024 (as reduced by the number of treasury sharesreported therein), and (ii) the aggregate number of Class B common shares beneficially owned by the Reporting Person.The aggregate number of Class B common shares beneficially owned by the Reporting Person as set forth in clauses (a)and (b) of this footnote are treated as converted into Class A common shares only for the purpose of computing thepercentage ownership of the Reporting Person. As of September 30, 2023, the number of Class A common sharesoutstanding was 44,009,699 and the percentage beneficially owned was 58.06percent. (3) Each Class A common share is entitled to one vote, and each Class B common share is entitled to ten votes. Thepercentage reported does not reflect the ten for one voting power of the Class B common shares because the Class Bcommon shares are treated as converted into Class A common shares for the purpose of this report.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A Common Shares, par value $0.00005 per share
    (b)Name of Issuer:

    Afya Ltd
    (c)Address of Issuer's Principal Executive Offices:

    ALAMEDA OSCAR NIEMEYER NO. 119, 15TH FLOOR, VILA DA SERRA, NOVA LIMA, BRAZIL , 34006-056.
    Item 1 Comment:
    Explanatory Note This Amendment No. 32 (the "Amendment") amends and supplements the Schedule 13D filed by the Reporting Person on August 10, 2021 (the "Original Schedule 13D", as further amended on March 4, 2022, "Amendment No. 1", as further amended on April 18, 2022, "Amendment No. 2", as further amended on April 25, 2022, "Amendment No. 3," as further amended on May 4, 2022, "Amendment No. 4," as further amended on May 23, 2022, "Amendment No. 5," as further amended on May 27, 2022, "Amendment No. 6," as further amended on August 1, 2022, "Amendment No. 7," as further amended on August 31, 2022, "Amendment No. 8," as further amended on September 23, 2022, "Amendment No. 9," as further amended on October 24, 2022, "Amendment No. 10," as further amended on November 9, 2022, "Amendment No. 11," as further amended on November 29, 2022, "Amendment No. 12," as further amended on December 16, 2022, "Amendment No. 13," as further amended on December 21, 2022, "Amendment No. 14," as further amended on January 12, 2023, "Amendment No. 15," as further amended on February 23, 2023, "Amendment No. 16," as further amended on March 29, 2023, "Amendment No. 17," as further amended on May 1, 2023, "Amendment No. 18," as further amended on June 20, 2023, "Amendment No. 19," as further amended on July 25, 2023, "Amendment No. 20," as further amended on September 7, 2023, "Amendment No. 21," as further amended on October 31, 2023, "Amendment No. 22," as further amended on December 12, 2023, "Amendment No. 23," as further amended on February 12, 2024, "Amendment No. 24," as further amended on March 19, 2024, "Amendment No. 25," as further amended on May 7, 2024, "Amendment No. 26," as further amended on May 22, 2024, "Amendment No. 27," as further amended on June 27, 2024, "Amendment No. 28," as further amended on July 23, 2024, "Amendment No. 29," as further amended on September 18, 2024, "Amendment No. 30," as further amended on October 31, 2024, "Amendment No. 31," and, as amended and supplemented by this Amendment, the "Schedule 13D"). Except as specifically provided herein, this Amendment does not modify any of the information previously reported on the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 13, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 27, Amendment No. 28, Amendment No. 29, Amendment No. 30 or Amendment No. 31. Capitalized terms not otherwise defined in this Amendment shall have the same meanings ascribed thereto in the Original Schedule 13D. This Schedule 13D relates to the Class A common shares, par value $0.00005, of Afya Limited, an exempted liability company incorporated under the laws of the Cayman Islands (the "Issuer"), having its registered offices at Alameda Oscar Niemeyer, No. 119, Salas 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas Gerais Brazil.
    Item 3.Source and Amount of Funds or Other Consideration
     
    This Amendment No. 32 amends and supplements Item 3 of the Original Schedule 13D (as amended by Amendment No. 3, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30 and Amendment No. 31) as follows: The Reporting Person purchased an additional 912,283 Class A common shares pursuant to the Trading Plan for a purchase price of $15,189,298.65, or an average of $16.65 per Class A common share. Such price was funded by the Reporting Person through internally generated funds.
    Item 5.Interest in Securities of the Issuer
    (a)
    This Amendment No. 32 amends and supplements Item 5 of the Original Schedule 13D (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30 and Amendment No. 31) as follows: The information relating to the beneficial ownership of Class A common shares by the Reporting Person as set forth in rows 7 through 13 of the cover pages hereto is incorporated by reference. The Reporting Person is the beneficial owner of 25,657,702 Class A common shares, which represents 55.26% of the Class A common shares outstanding based on 46,426,830 Class A common shares outstanding as of September 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Commission on November 13, 2024 (as reduced by the number of treasury shares reported therein). Except as set forth in this Item 5(a), the Reporting Person does not own beneficially any Class A common shares. The Reporting Person will provide upon request of the SEC staff the full information regarding the number of shares purchased or sold at each separate price.
    (b)
    This Amendment No. 32 amends and supplements Item 5 of the Original Schedule 13D (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30 and Amendment No. 31) as follows: The Reporting Person has shared power to vote and dispose of 25,657,702 Class A common shares.
    (c)
    This Amendment No. 32 amends and supplements Item 5 of the Original Schedule 13D (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30 and Amendment No. 31) as follows: The Reporting Person has purchased the following Class A common shares in open market transactions pursuant to the Trading Plan since the filing of the Schedule 13D/A on October 31, 2024: Transaction Date Class A Common Shares Purchased Average Price Per Share October 30, 2024 30,090 16.93 October 31, 2024 30,090 16.81 November 1, 2024 27,859 17.26 November 4, 2024 28,962 17.65 November 5, 2024 14,974 17.95 November 6, 2024 28,962 17.97 November 7, 2024 28,962 17.92 November 8, 2024 28,962 17.64 November 11, 2024 29,233 17.95 November 12, 2024 29,233 17.71 November 13, 2024 29,018 17.45 November 14, 2024 29,233 16.07 November 15, 2024 29,233 15.99 November 18, 2024 30,309 16.44 November 19, 2024 24,967 16.46 November 20, 2024 24,197 16.35 November 21, 2024 30,309 16.42 November 22, 2024 24,073 16.80 November 25, 2024 18,398 16.92 November 26, 2024 26,161 16.99 November 27, 2024 26,015 17.12 November 29, 2024 15,511 16.40 December 2, 2024 24,450 16.67 December 3, 2024 26,584 15.68 December 4, 2024 14,811 16.04 December 5, 2024 26,584 16.48 December 6, 2024 26,584 16.36 December 9, 2024 27,775 16.18 December 10, 2024 22,057 16.07 December 11, 2024 26,309 16.08 December 12, 2024 27,775 15.88 December 13, 2024 27,775 15.73 December 16, 2024 25,683 15.54 December 17, 2024 25,682 15.24 December 18, 2024 25,463 15.05

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Bertelsmann SE & Co. KGaA
     
    Signature:ppa /s/ Martin Dannhoff
    Name/Title:Martin Dannhoff, SVP Corporate Legal
    Date:12/20/2024
     
    Signature:ppa /s/ Denise Abel
    Name/Title:Denise Abel, SVP Corporate Legal
    Date:12/20/2024
     
    Erste WV Gutersloh GmbH
     
    Signature:/s/ Martin Dannhoff
    Name/Title:Martin Dannhoff, Director
    Date:12/20/2024
     
    Signature:/s/ Denise Abel
    Name/Title:Denise Abel, Director
    Date:12/20/2024
    Get the next $AFYA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AFYA

    DatePrice TargetRatingAnalyst
    3/11/2025$19.00 → $17.00Equal-Weight → Underweight
    Morgan Stanley
    1/31/2025$18.00 → $15.00Neutral → Sell
    Citigroup
    12/3/2024$16.00Sell
    Goldman
    8/30/2024$19.50Neutral
    UBS
    1/29/2024$23.00Neutral
    Citigroup
    1/22/2024$20.50 → $23.00Overweight → Equal-Weight
    Morgan Stanley
    10/13/2023$16.50 → $20.50Equal-Weight → Overweight
    Morgan Stanley
    4/8/2022$18.00 → $19.00Neutral → Outperform
    Credit Suisse
    More analyst ratings

    $AFYA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Afya Limited Announces First-Quarter 2025 Financial Results

      Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue increased 16.4% YoY to R$936.4 million. Net Revenue excluding acquisitions increased 10.9%, reaching R$891.5 million. 1Q25 Adjusted

      5/8/25 8:11:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Closing of the Acquisition of FACULDADE ÚNICA DE CONTAGEM

      Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the company on December 19th, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Masterclass Ltda. ("FACULDADE ÚNICA DE CONTAGEM" or "FUNIC"), located in Contagem, a city in the metropolitan area of Belo Horizonte, the capital of the State of Minas Gerais. The acquisition contributes 60 medical school seats to Afya. FUNIC is pre-operational, with leased real estate prepared for a medi

      5/7/25 5:27:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

      Impressive Adjusted EBITDA Margin Expansion Expressive Cash Generation First Dividend Announcement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue increased 16.3% YoY to R$849.0 million. Net Revenue excluding acquisitions increased 12.0%, reaching R$817.8 million. 4Q24 Adjust

      3/13/25 5:45:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Financials

    Live finance-specific insights

    See more
    • Afya Limited Announces First-Quarter 2025 Financial Results

      Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue increased 16.4% YoY to R$936.4 million. Net Revenue excluding acquisitions increased 10.9%, reaching R$891.5 million. 1Q25 Adjusted

      5/8/25 8:11:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

      Impressive Adjusted EBITDA Margin Expansion Expressive Cash Generation First Dividend Announcement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue increased 16.3% YoY to R$849.0 million. Net Revenue excluding acquisitions increased 12.0%, reaching R$817.8 million. 4Q24 Adjust

      3/13/25 5:45:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces First Dividend Distribution of R$129.8 Million

      Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), Brazil's leading medical education group and provider of medical practice solutions, announced that its board of directors (the "Board") approved its first distribution of a cash dividend. On March 12, 2025, Afya's Board declared a cash dividend of R$129.8 million, representing 20% of the Company's consolidated net income of R$648.9 million for the year ended December 31, 2024. This amounts to a dividend per share (DPS) of R$1.348923, payable in U.S. dollars on April 4, 2025, to shareholders of record as of the close of business on March 26, 2025. The payment will be made at the exchange rate (PTAX) published on March 13, 2

      3/13/25 4:57:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 5:15:03 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 4:21:17 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 4:18:15 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Afya downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Afya from Equal-Weight to Underweight and set a new price target of $17.00 from $19.00 previously

      3/11/25 7:14:11 AM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya downgraded by Citigroup with a new price target

      Citigroup downgraded Afya from Neutral to Sell and set a new price target of $15.00 from $18.00 previously

      1/31/25 8:29:57 AM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Goldman initiated coverage on Afya with a new price target

      Goldman initiated coverage of Afya with a rating of Sell and set a new price target of $16.00

      12/3/24 8:02:22 AM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    SEC Filings

    See more
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/8/25 4:13:04 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/8/25 4:09:46 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/7/25 4:18:35 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Leadership Updates

    Live Leadership Updates

    See more
    • Afya Limited Announces that Whitebook was ranked as one of the 10 Top Apps in Brazil by Consumer Spend in 2020

      NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announces that its clinical decision software, WhiteBook, an app created by PEBMED, was ranked as one of the 10 Top Apps in Brazil by consumer spend in 2020 for the fifth year in a row. App Annie conducted the study, a website specialized in app analytics and app market data that combined data from iOS and Google Play that evaluates more than 8 million mobile app per year. In the top ten WhiteBook was among great apps such as Tinder, YouTube, Netflix, TikTok and others. Whitebook is a mobile and web application software that helps doctors and medical students to make

      1/15/21 8:55:10 AM ET
      $AFYA
      Other Consumer Services
      Real Estate